Link for asbestos-free talcum powder, cancer not clear

Link for asbestos-free talcum powder, cancer not clear

(HealthDay)—Talcum powder, made from talc, which contains asbestos is considered carcinogenic to humans, while the carcinogenicity of talc without asbestos is unclear, according to the American Cancer Society.

Talcum powder is widely used in cosmetic products. Some talc contains asbestos, although all talcum products used in homes in the United States have been free from asbestos since the 1970s.

In laboratory studies, exposure of rats, mice, and hamsters to asbestos-free talc resulted in mixed findings, with tumor formation in some studies. Findings from studies in women that examined the possible link between talcum powder and ovarian cancer were mixed, with some studies showing a slightly increased . A small increase in risk was seen in many case-control studies. No increased risk was seen in one , while a modestly increased risk was seen in a second study. Increased risk of and other respiratory diseases has been seen in some studies of talc miners and millers. Lung cancer risk was not increased with reports of cosmetic talcum powder use. One study suggested increased risk of endometrial cancer with genital talcum powder use.

The International Agency for Research on Cancer classifies talc that contains asbestos as "carcinogenic to humans," while talc not containing asbestos is "not classifiable as to carcinogenicity in humans." Perineal use of talc-based body powder is classified as "possibly carcinogenic to humans."

More information: More Information

Copyright © 2018 HealthDay. All rights reserved.

Citation: Link for asbestos-free talcum powder, cancer not clear (2018, July 19) retrieved 25 April 2024 from https://medicalxpress.com/news/2018-07-link-asbestos-free-talcum-powder-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

J&J ordered to pay $4.69 bn damages in talc cancer case

3 shares

Feedback to editors